|
1
|
Printz C: American Cancer Society reports
progress in reducing cancer deaths: However, some groups still lag
behind this trend. Cancer. 117:4573–4574. 2011. View Article : Google Scholar
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar
|
|
4
|
Pekkola-Heino K, Servomaa K, Kiuru A and
Grenman R: Increased radiosensitivity is associated with p53
mutations in cell lines derived from oral cavity carcinoma. Acta
Otolaryngol. 116:341–344. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huerta S, Gao X, Dineen S, Kapur P, Saha D
and Meyer J: Role of p53, Bax, p21, and DNA-PKcs in radiation
sensitivity of HCT-116 cells and xenografts. Surgery. 154:143–151.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berthet C, Guéhenneux F, Revol V, Samarut
C, Lukaszewicz A, Dehay C, Dumontet C, Magaud JP and Rouault JP:
Interaction of PRMT1 with BTG/TOB proteins in cell signalling:
Molecular analysis and functional aspects. Genes Cells. 7:29–39.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rouault JP, Rimokh R, Tessa C, Paranhos G,
Ffrench M, Duret L, Garoccio M, Germain D, Samarut J and Magaud JP:
BTG1, a member of a new family of antiproliferative genes. EMBO J.
11:1663–1670. 1992.PubMed/NCBI
|
|
8
|
Matsuda S, Rouault J, Magaud J and Berthet
C: In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS
Lett. 497:67–72. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bakker WJ, Blázquez-Domingo M, Kolbus A,
Besooyen J, Steinlein P, Beug H, Coffer PJ, Löwenberg B, von
Lindern M and van Dijk TB: FoxO3a regulates erythroid
differentiation and induces BTG1, an activator of protein arginine
methyl transferase 1. J Cell Biol. 164:175–184. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Corjay MH, Kearney MA, Munzer DA, Diamond
SM and Stoltenborg JK: Antiproliferative gene BTG1 is highly
expressed in apoptotic cells in macrophage-rich areas of advanced
lesions in Watanabe heritable hyperlipidemic rabbit and human. Lab
Invest. 78:847–858. 1998.PubMed/NCBI
|
|
11
|
Rodier A, Marchal-Victorion S, Rochard P,
Casas F, Cassar-Malek I, Rouault JP, Magaud JP, Mason DY, Wrutniak
C and Cabello G: BTG1: A triiodothyronine target involved in the
myogenic influence of the hormone. Exp Cell Res. 249:337–348. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee H, Cha S, Lee MS, Cho GJ, Choi WS and
Suk K: Role of antiproliferative B cell translocation gene-1 as an
apoptotic sensitizer in activation-induced cell death of brain
microglia. J Immunol. 171:5802–5811. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sheng SH, Zhao CM and Sun GG: BTG1
expression correlates with the pathogenesis and progression of
breast carcinomas. Tumour Biol. 35:3317–3326. 2014. View Article : Google Scholar
|
|
14
|
Li W, Zou ST, Zhu R, Wan JM, Xu Y and Wu
HR: B-cell translocation 1 gene inhibits cellular
metastasis-associated behavior in breast cancer. Mol Med Rep.
9:2374–2380. 2014.PubMed/NCBI
|
|
15
|
Wu X, Ding N, Hu W, He J, Xu S, Pei H, Hua
J, Zhou G and Wang J: Down-regulation of BTG1 by miR-454-3p
enhances cellular radiosensitivity in renal carcinoma cells. Radiat
Oncol. 9:1792014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu R, Zou ST, Wan JM, Li W, Li XL and Zhu
W: BTG1 inhibits breast cancer cell growth through induction of
cell cycle arrest and apoptosis. Oncol Rep. 30:2137–2144.
2013.PubMed/NCBI
|
|
17
|
Peters LJ, Withers HR, Thames HD Jr and
Fletcher GH: Tumor radioresistance in clinical radiotherapy. Int J
Radiat Oncol Biol Phys. 8:101–108. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Deacon J, Peckham MJ and Steel GG: The
radioresponsiveness of human tumours and the initial slope of the
cell survival curve. Radiother Oncol. 2:317–323. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wyld L, Smith O, Lawry J, Reed MW and
Brown NJ: Cell cycle phase influences tumour cell sensitivity to
aminolaevulinic acid-induced photodynamic therapy in vitro. Br J
Cancer. 78:50–55. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Efeyan A and Serrano M: p53: Guardian of
the genome and policeman of the oncogenes. Cell Cycle. 6:1006–1010.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duan X, Zhang H, Liu B, Li XD, Gao QX and
Wu ZH: Apoptosis of murine melanoma cells induced by heavy-ion
radiation combined with Tp53 gene transfer. Int J Radiat Biol.
84:211–217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hill R, Bodzak E, Blough MD and Lee PW:
p53 binding to the p21 promoter is dependent on the nature of DNA
damage. Cell Cycle. 7:2535–2543. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hwang A, McKenna WG and Muschel RJ: Cell
cycle-dependent usage of transcriptional start sites. A novel
mechanism for regulation of cyclin B1. J Biol Chem.
273:31505–31509. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ozeki M, Tamae D, Hou DX, Wang T, Lebon T,
Spitz DR and Li JJ: Response of cyclin B1 to ionizing radiation:
Regulation by NF-kappaB and mitochondrial antioxidant enzyme MnSOD.
Anticancer Res. 24:2657–2663. 2004.PubMed/NCBI
|
|
25
|
Raj D, Liu T, Samadashwily G, Li F and
Grossman D: Survivin repression by p53, Rb and E2F2 in normal human
melanocytes. Carcinogenesis. 29:194–201. 2008. View Article : Google Scholar
|
|
26
|
Hassan KA, Ang KK, El-Naggar AK, Story MD,
Lee JI, Liu D, Hong WK and Mao L: Cyclin B1 overexpression and
resistance to radiotherapy in head and neck squamous cell
carcinoma. Cancer Res. 62:6414–6417. 2002.PubMed/NCBI
|
|
27
|
Lee CH, Jeon YT, Kim SH and Song YS:
NF-kappaB as a potential molecular target for cancer therapy.
Biofactors. 29:19–35. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cory S, Huang DC and Adams JM: The Bcl-2
family: Roles in cell survival and oncogenesis. Oncogene.
22:8590–8607. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chang L, Graham PH, Hao J, Ni J, Bucci J,
Cozzi PJ, Kearsley JH and Li Y: Acquisition of
epithelial-mesenchymal transition and cancer stem cell phenotypes
is associated with activation of the PI3K/Akt/mTOR pathway in
prostate cancer radioresistance. Cell Death Dis. 4:e8752013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chang L, Graham PH, Hao J, Bucci J, Cozzi
PJ, Kearsley JH and Li Y: Emerging roles of radioresistance in
prostate cancer metastasis and radiation therapy. Cancer Metastasis
Rev. 33:469–496. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schulz JB, Bremen D, Reed JC, Lommatzsch
J, Takayama S, Wüllner U, Löschmann PA, Klockgether T and Weller M:
Cooperative interception of neuronal apoptosis by BCL-2 and BAG-1
expression: Prevention of caspase activation and reduced production
of reactive oxygen species. J Neurochem. 69:2075–2086. 1997.
View Article : Google Scholar
|
|
32
|
Goossens V, De Vos K, Vercammen D,
Steemans M, Vancompernolle K, Fiers W, Vandenabeele P and Grooten
J: Redox regulation of TNF signaling. Biofactors. 10:145–156. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Simizu S, Takada M, Umezawa K and Imoto M:
Requirement of caspase-3(-like) protease-mediated hydrogen peroxide
production for apoptosis induced by various anticancer drugs. J
Biol Chem. 273:26900–26907. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chan WH, Yu JS and Yang SD: PAK2 is
cleaved and activated during hyperosmotic shock-induced apoptosis
via a caspase-dependent mechanism: Evidence for the involvement of
oxidative stress. J Cell Physiol. 178:397–408. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vercammen D, Brouckaert G, Denecker G, Van
de Craen M, Declercq W, Fiers W and Vandenabeele P: Dual signaling
of the Fas receptor: Initiation of both apoptotic and necrotic cell
death pathways. J Exp Med. 188:919–930. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mikkelsen RB and Wardman P: Biological
chemistry of reactive oxygen and nitrogen and radiation-induced
signal transduction mechanisms. Oncogene. 22:5734–5754. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gamaley IA and Klyubin IV: Roles of
reactive oxygen species: Signaling and regulation of cellular
functions. Int Rev Cytol. 188:203–255. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cerutti PA: Prooxidant states and tumor
promotion. Science. 227:375–381. 1985. View Article : Google Scholar : PubMed/NCBI
|
